Recombinant human vascular endothelial growth factor enhaces bone healing in an experimental nonunion model

137Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

Abstract

The re-establishment of vascularity is an early event in fracture healing; upregulation of angiogenesis may therefore promote the formation of bone. We have investigated the capacity of vascular endothelial growth factor (VEGF) to stimulate the formation of bone in an experimental atrophic nonunion model. Three groups of eight rabbits underwent a standard nonunion operation. This was followed by interfragmentary deposition of 100 μg VEGF, carrier alone or autograft. After seven weeks, torsional failure tests and callus size confirmed that VEGF-treated osteotomies had united whereas the carrier-treated osteotomies failed to unite. The biomechanical properties of the groups treated with VEGF and autograft were identical. There was no difference in bone blood flow. We considered that VEGF stimulated the formation of competent bone in an environment deprived of its normal vascularisation and osteoprogenitor cell supply. It could be used to enhance the healing of fractures predisposed to nonunion. © 2005 British Editorial Society of Bone and Joint Surgery.

Cite

CITATION STYLE

APA

Eckardt, H., Ding, M., Lind, M., Hansen, E. S., Christensen, K. S., & Hvid, I. (2005). Recombinant human vascular endothelial growth factor enhaces bone healing in an experimental nonunion model. Journal of Bone and Joint Surgery - Series B, 87(10), 1434–1438. https://doi.org/10.1302/0301-620X.87B10.16226

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free